Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy MEDIFAST stock
Learn how to easily invest in MEDIFAST stock.
MEDIFAST is a personal services business based in the US. MEDIFAST shares (MED) are listed on the NYSE and all prices are listed in US Dollars. MEDIFAST employs 874 staff and has a trailing 12-month revenue of around $1.5 billion.
How to buy MEDIFAST stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MED. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
MEDIFAST stock price (NYSE: MED)Use our graph to track the performance of MED stocks over time.
MEDIFAST shares at a glance
|Latest market close||$78.70|
|52-week range||$80.52 - $183.52|
|50-day moving average||$93.71|
|200-day moving average||$111.34|
|Wall St. target price||$71.00|
|Dividend yield||$6.57 (8.04%)|
|Earnings per share (TTM)||$12.81|
Buy MEDIFAST stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy MEDIFAST stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MEDIFAST price performance over time
Historical closes compared with the close of $78.7 from 2023-05-31
|1 week (2023-05-25)||-4.88%|
|1 month (2023-05-01)||-13.11%|
|3 months (2023-02-28)||-29.81%|
|6 months (2022-11-30)||-37.56%|
|1 year (2022-05-28)||N/A|
|2 years (2021-05-28)||-76.31%|
|3 years (2020-06-01)||100.5519|
|5 years (2018-06-01)||136.8069|
Is MEDIFAST stock undervalued or overvalued?
Valuing MEDIFAST stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDIFAST's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDIFAST's P/E ratio
MEDIFAST's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, MEDIFAST shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
MEDIFAST's PEG ratio
MEDIFAST's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDIFAST's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDIFAST's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $194.7 million.
The EBITDA is a measure of a MEDIFAST's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.5 billion|
|Operating margin TTM||11.98%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||30.82%|
|Return on equity TTM||73.27%|
|Market capitalisation||$893.8 million|
TTM: trailing 12 months
MEDIFAST share dividends
Dividend payout ratio: 48.2% of net profits
Recently MEDIFAST has paid out, on average, around 48.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.04% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MEDIFAST shareholders could enjoy a 8.04% return on their shares, in the form of dividend payments. In MEDIFAST's case, that would currently equate to about $6.57 per share.
While MEDIFAST's payout ratio might seem fairly standard, it's worth remembering that MEDIFAST may be investing much of the rest of its net profits in future growth.
MEDIFAST's most recent dividend payout was on 9 May 2023. The latest dividend was paid out to all shareholders who bought their shares by 27 March 2023 (the "ex-dividend date").
MEDIFAST share price volatility
Over the last 12 months, MEDIFAST's shares have ranged in value from as little as $80.52 up to $183.5243. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDIFAST's is 1.2607. This would suggest that MEDIFAST's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medifast, Inc. , through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland. .
MEDIFAST in the news
Medifast (MED) Down 8.2% Since Last Earnings Report: Can It Rebound?
Investors one-year losses continue as Medifast (NYSE:MED) dips a further 8.6% this week, earnings continue to decline
15 Best Diets in 2023
Frequently asked questionsWhat percentage of MEDIFAST is owned by insiders or institutions?
Currently 1.986% of MEDIFAST shares are held by insiders and 88.347% by institutions. How many people work for MEDIFAST?
Latest data suggests 874 work at MEDIFAST. When does the fiscal year end for MEDIFAST?
MEDIFAST's fiscal year ends in December. Where is MEDIFAST based?
MEDIFAST's address is: 100 International Drive, Baltimore, MD, United States, 21202 What is MEDIFAST's ISIN number?
MEDIFAST's international securities identification number is: US58470H1014 What is MEDIFAST's CUSIP number?
MEDIFAST's Committee on Uniform Securities Identification Procedures number is: 42221F101
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert